Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

World Federation of Societies of Biological Psychiatry (WFSBP) consensus statement on candidate biomarkers for anorexia nervosa.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2026
Same author

Immune System Controls Gut Bacterial and Host Peptide Signals in Appetite Regulation: Towards Specific Immunotherapy of Eating Disorders.

Neuroimmunomodulation·2026
Same author

Targeted proteomics reveal α-MSH-like Enterobacterial ClpB protein in gut microbiota of patients with anorexia nervosa.

NPJ biofilms and microbiomes·2025
Same author

Imbalanced Innervation of the Hypothalamic Paraventricular Nucleus by the AgRP and α-Melanocyte-Stimulating Hormone Axonal Projections in Germ-Free Mice.

Developmental neuroscience·2025
Same author

Immunization reveals a key role of Enterobacterial ClpB protein in the development of host anorexia.

Brain, behavior, and immunity·2025
Same author

Enterobacterial caseinolytic protease B (ClpB) and ClpB antibodies in adolescents with anorexia nervosa.

Journal of psychiatric research·2025

Related Experiment Video

Updated: May 29, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood

Published on: January 9, 2018

Neuropeptide autoantibodies assay.

Sergueï O Fetissov1

  • 1Digestive System and Nutrition Laboratory (ADEN EA4311), Rouen University, Rouen, France. Serguei.Fetissov@univ-rouen.fr

Methods in Molecular Biology (Clifton, N.J.)
|September 17, 2011
PubMed
Summary

This study presents a new ELISA method to measure autoantibodies against neuropeptides in serum. It distinguishes between free and immune-complexed autoantibodies, applicable to various molecules and fluids.

Area of Science:

  • Immunology
  • Neuroscience
  • Biochemistry

Background:

  • Autoantibodies against neuropeptides are implicated in various autoimmune neurological disorders.
  • Quantifying autoantibodies, especially those within immune complexes, is crucial for understanding disease pathogenesis.
  • Existing methods may not differentiate between free and bound autoantibodies effectively.

Purpose of the Study:

  • To describe a novel ELISA-based protocol for quantifying serum autoantibodies reactive with neuropeptides.
  • To enable the measurement of both free and immune-complexed autoantibodies.
  • To provide a versatile method applicable to diverse autoantigens and biological samples.

Main Methods:

  • Development of an Enzyme-Linked Immunosorbent Assay (ELISA) protocol.

More Related Videos

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Experiment Videos

Last Updated: May 29, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood

Published on: January 9, 2018

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

  • Utilized two distinct sample buffers: one under normal conditions and another under dissociative conditions.
  • Assayed serum samples for autoantibodies targeting neuropeptides.

    • Main Results:

    • The protocol successfully quantifies relative serum levels of autoantibodies reactive with neuropeptides.
    • The method differentiates between free autoantibodies and those sequestered within immune complexes.
    • Demonstrated the applicability of the method to measure autoantibodies against non-neuropeptide molecules.

    Conclusions:

    • This ELISA protocol offers a robust approach for measuring autoantibodies against neuropeptides.
    • The ability to distinguish free from bound autoantibodies provides deeper insights into autoimmune processes.
    • The method's adaptability makes it valuable for broader applications in autoimmunity research across various molecules and biological fluids.